Vanja Vlajnic

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction”.

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

JAMA(2020)10.1001/jama.2020.15922

N/A

5.3DataRank · unranked

278 citations

Carolyn S.P. Lam, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor +14 more

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0DataRank · unranked

37 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more